Zymeworks
ZYME
97 hedge funds and large institutions have $452M invested in Zymeworks in 2022 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 32 increasing their positions, 17 reducing their positions, and 26 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
88% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 17
54% more capital invested
Capital invested by funds: $294M → $452M (+$158M)
27% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 26
13.82% more ownership
Funds ownership: 77.44% → 91.25% (+14%)
7% more funds holding
Funds holding: 91 → 97 (+6)
1% more call options, than puts
Call options by funds: $1.8M | Put options by funds: $1.77M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$53.2M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$41.2M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$21.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.1M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$35.6M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$33.1M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$17.6M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$9.24M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$6.7M |
ZYME Hedge Fund Activity: Q4 2022 in Review
97 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q4 2022, worth a combined $452M — up 54% from $294M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new ZYME positions and 26 closed out — a net gain of 7 holders — while 32 added to existing stakes and 17 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $53.2M. The largest seller was Armistice Capital, exiting entirely with an estimated $35.6M sold.
- 97 institutional investors held Zymeworks (ZYME) as of Q4 2022, up from 91 in Q3 2022.
- Funds reported $452M of Zymeworks stock for Q4 2022, up 54% quarter-over-quarter.
- 33 funds opened new Zymeworks positions in Q4 2022 and 26 closed out, a net change of +7 holders.
- The largest Zymeworks buyer in Q4 2022 was EcoR1 Capital, an estimated $53.2M added.
- The largest Zymeworks seller in Q4 2022 was Armistice Capital, an estimated $35.6M sold.
Based on aggregated 13F filings for Q4 2022.